Prognostic Biomarkers Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Cases of Disease Recurrence
- Growing Health Awareness Among People
Challenges
- Unavailability of Proper Advanced Technology in Developing Nations
- High Cost of Prognostics Biomarkers
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Prognostic Biomarkers Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2025-2037.
Rising cases of chronic disease recurrence will impel the market growth.
North America industry is predicted to account for largest revenue share by 2037, on the back of increasing health awareness among people, along with high per capita healthcare expenditure by the government.
The major players in the market are PerkinElmer Inc., Myriad Genetics, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., and others.
